Volume 4, Issue 6: P. aeruginosa Eradication - PODCAST
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 4, Issue 6)
Target Audience
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Discuss the rationale for early Pseudomonas aeruginosa eradication
- Identify the inhaled and oral antibiotics compared in clinical trials of early Pseudomonas aeruginosa eradication therapy.
- Describe potential adverse effects of early Pseudomonas aeruginosa eradication therapy
Margaret Rosenfeld, MD, MPH
Professor
Division of Pulmonary Medicine
Seattle Children’s Hospital and Department of Pediatrics
University of Washington School of Medicine
Seattle, Washington
Available Credit
- 0.50 ANCC